InChI=1S/C17H26N2O.ClH/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3;/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20);1H/t15-;/m0./s1 |
NDNSIBYYUOEUSV-RSAXXLAASA-N |
[Cl-].CCC[NH+]1CCCC[C@H]1C(=O)Nc1c(C)cccc1C |
|
local anaesthetic
Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block.
|
|
View more via ChEBI Ontology
(2S)-2-[(2,6-dimethylphenyl)carbamoyl]-1-propylpiperidinium chloride
|
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride
|
(S)-(—)-1-propyl-2',6'-pipecoloxylidide hydrochloride
|
ChEBI
|
(S)-1-propyl-2-piperidylformo-2',6'-xylidide hydrochloride
|
ChEBI
|
(S)-ropivacaine HCl
|
ChEBI
|
(S)-ropivacaine monohydrochloride (anhydrous)
|
ChEBI
|
L-N-n-propylpipecolic acid-2,6-xylidide hydrochloride
|
ChEBI
|
L-ropivacaine HCl
|
ChEBI
|
L-ropivacaine hydrochloride
|
ChEBI
|
ropivacaine HCl
|
ChemIDplus
|
ropivacaine hydrochloride
|
ChemIDplus
|
ropivacaine monohydrochloride
|
ChemIDplus
|
6023239
|
Reaxys Registry Number
|
Reaxys
|
98717-15-8
|
CAS Registry Number
|
ChemIDplus
|
|